ArticleAllergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology2010

Omalizumab: Practical considerations regarding the risk of anaphylaxis.

Harold L Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.